See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Research Videos on Diabetes Health TV

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

Research Archives

Diabetes Research

Page 2
FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until "previously observed deficiencies" at the plant where it is manufactured are fixed.

Comments 0 comments - Mar 23, 2014 - * * * * *

Both High and Low A1c's Implicated in Longer Hospital Stays

An interesting study out of Brigham and Women's hospital in Boston ties poor glycemic control--defined as an A1c of 8% or more--to longer hospital stays for non-cardiac surgery.

Comments 0 comments - Mar 20, 2014 - * * * * *

Marijuana May Help Blood Sugar Control, Study Says

For residents of Colorado and Washington state, 2014 brought a profound legal and societal change. Marijuana is now available, legally, in both of those states. While the drug is cleared for medical use elsewhere, and other jurisdictions have decriminalized it, these two states have taken the profound, extra step of full legalization.

Comments 0 comments - Mar 15, 2014 - * * * * *

Celebrating 30 years of the DCCT: Part 2

Three decades ago, the landmark Diabetes Control and Complications Study was just beginning. To mark the anniversary of the most important advancement in diabetes care in most of our lifetimes, I've been recalling how the study came about and what it revealed. In short, the DCCT proved the tight control of type 1 diabetes not only was an achievable goal, but that it prevented or delayed complications.

Comments 0 comments - Mar 11, 2014 - * * * * *

Celebrating 30 Years of the DCCT: Part 1

What do three decades mean to you? In absolute terms, 30 years is a serious amount of time. If you're under the age of 40, for example, it's the vast majority of your life. But in the world of medical research, where studies can take many years to complete--and even longer to affect everyday practice--three decades can go by surprisingly quickly.

Comments 0 comments - Mar 10, 2014 - * * * * *

Rare Mutation Destroys Gene Associated With Type 2

A recent New York Times article reports that researchers have found a rare mutation that reduces the risk of developing type 2 diabetes by two thirds, even in obese people.

Comments 0 comments - Mar 9, 2014 - * * * * *

57% of Type 1s Expect a Cure by 2024

New York, NY (PRWEB)--More than half of people who have type 1 diabetes or have a family member or close friend with the disease expect a cure to be found in the next 10 years, according to a semi-annual survey conducted by the Juvenile Diabetes Cure Alliance.

Comments 0 comments - Mar 8, 2014 - * * * * *

Mouth Spray Could Aid Weight Loss

Few things are better for us or more difficult to sustain than losing weight. Whatever the cause--genetics, environment, our own bad choices--human bodies can be easily turned into sugar-craving machines. Turning our bodies from that course is easy enough for a week or three, but sustaining weight loss over many months and years is notoriously difficult.

Comments 0 comments - Mar 7, 2014 - * * * * *

Life-Prolonging Chemical Could Someday Lead to Type 2 Treatment

A recent article in Scientific American discusses a synthetic chemical that has extended the lifespan of lab mice by mimicking the effects of a low-calorie diet.

Comments 0 comments - Mar 6, 2014 - * * * * *

FDA Backtracks Over GLP-1s' Effects on Pancreas

The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a link between GLP-1 drugs used to treat type 2 diabetes and pancreatic maladies, including acute pancreatitis and pancreatic cancer.

Comments 0 comments - Mar 4, 2014 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.